Octagon Capital Advisors LP
27 holdingsFiling period: 2026-06-30Current AUM: $769.7Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | DNTH | Dianthus Therapeutics Inc | 1.84M | $179.5M | $145.0M | 18.84% | -105,000 | 2026-06-30 |
| 2 | DFTX | Definium Therapeutics Inc | 2.95M | $138.8M | $103.5M | 13.45% | +510.0K | 2026-06-30 |
| 3 | ABVX | Abivax SA | 993.0K | $132.3M | $91.9M | 11.95% | +316.0K | 2026-06-30 |
| 4 | COGT | Cogent Biosciences Inc | 2.35M | $90.9M | $73.4M | 9.54% | -- | 2026-06-30 |
| 5 | ALMS | Alumis Inc | 2.83M | $79.7M | $19.0M | 2.46% | -- | 2026-06-30 |
| 6 | AVBP | Arrivent Biopharma Inc | 1.97M | $68.5M | $37.2M | 4.83% | -- | 2026-06-30 |
| 7 | TSHA | Taysha Gene Therapies Inc | 9.69M | $66.0M | $39.8M | 5.18% | +833.3K | 2026-06-30 |
| 8 | BIOA | Bioage Labs Inc | 1.75M | $42.8M | $9.7M | 1.26% | -- | 2026-06-30 |
| 9 | MIRM | Mirum Pharmaceuticals Inc | 338.9K | $39.7M | $28.8M | 3.75% | -- | 2026-06-30 |
| 10 | KYMR | Kymera Therapeutics Inc | 310.0K | $35.5M | $35.2M | 4.57% | -115,000 | 2026-06-30 |
| 11 | AKTS | Aktis Oncology Inc | 960.8K | $31.0M | $15.5M | 2.01% | -- | 2026-06-30 |
| 12 | XENE | Xenon Pharmaceuticals Inc | 490.0K | $29.6M | $17.8M | 2.31% | -- | 2026-06-30 |
| 13 | ERAS | Erasca Inc | 1.25M | $23.0M | $18.3M | 2.38% | -- | 2026-06-30 |
| 14 | PALI | Palisade Bio Inc | 10.28M | $21.5M | $14.7M | 1.91% | -- | 2026-06-30 |
| 15 | OCUL | Ocular Therapeutix Inc | 2.08M | $20.4M | $13.8M | 1.79% | -1,091,600 | 2026-06-30 |
| 16 | IRON | Disc Medicine Inc | 270.0K | $19.7M | $21.5M | 2.79% | -- | 2026-06-30 |
| 17 | SMMT | Summit Therapeutics Inc | 1.25M | $18.2M | $20.1M | 2.61% | -- | 2026-06-30 |
| 18 | — | Pharvaris N V | 456.7K | $15.8M | $15.8M | 2.05% | +291.7K | 2026-06-30 |
| 19 | ANL | Adlai Nortye Ltd | 934.7K | $10.7M | $9.9M | 1.29% | -- | 2026-06-30 |
| 20 | DTIL | Precision Biosciences Inc | 1.35M | $10.6M | $8.9M | 1.15% | -886,732 | 2026-06-30 |
| 21 | DBVT | Dbv Technologies S A | 574.2K | $9.4M | $5.4M | 0.71% | -- | 2026-06-30 |
| 22 | SNSE | Faeth Therapeutics Inc | 361.0K | $9.0M | $9.0M | 1.17% | -- | 2026-06-30 |
| 23 | GYRE | Gyre Therapeutics Inc | 954.4K | $6.3M | $5.9M | 0.77% | -- | 2026-06-30 |
| 24 | TRVI | Trevi Therapeutics Inc | 315.0K | $5.9M | $4.0M | 0.53% | -1,170,000 | 2026-06-30 |
| 25 | UNCY | Unicycive Therapeutics Inc | 1.00M | $4.7M | $3.8M | 0.49% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2